S

Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506

Watchlist Manager
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
Watchlist
Price: 195.32 CNY -1.89% Market Closed
Market Cap: 78.3B CNY
Have any thoughts about
Sichuan Biokin Pharmaceutical Co Ltd?
Write Note
Sichuan Biokin Pharmaceutical Co Ltd
/
Cash Flow Statement
/
Effect of Foreign Exchange Rates

Sichuan Biokin Pharmaceutical Co Ltd
Effect of Foreign Exchange Rates

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Sichuan Biokin Pharmaceutical Co Ltd
Effect of Foreign Exchange Rates Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Effect of Foreign Exchange Rates CAGR 3Y CAGR 5Y CAGR 10Y
S
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
Effect of Foreign Exchange Rates
-¥2.6m
CAGR 3-Years
-9%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Effect of Foreign Exchange Rates
-¥122.4m
CAGR 3-Years
46%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Effect of Foreign Exchange Rates
¥5.2m
CAGR 3-Years
N/A
CAGR 5-Years
-5%
CAGR 10-Years
N/A
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Effect of Foreign Exchange Rates
-¥28.4m
CAGR 3-Years
31%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Yunnan Baiyao Group Co Ltd
SZSE:000538
Effect of Foreign Exchange Rates
-¥3m
CAGR 3-Years
8%
CAGR 5-Years
N/A
CAGR 10-Years
-9%
C
CSPC Innovation Pharmaceutical Co Ltd
SZSE:300765
Effect of Foreign Exchange Rates
¥20.8m
CAGR 3-Years
168%
CAGR 5-Years
60%
CAGR 10-Years
N/A
No Stocks Found

Sichuan Biokin Pharmaceutical Co Ltd
Glance View

Market Cap
78.3B CNY
Industry
Pharmaceuticals

Sichuan Biokin Pharmaceutical Co., Ltd. is an emerging player in the pharmaceutical landscape of China, specializing in the research, development, and manufacturing of innovative biopharmaceuticals. Founded in 2003, the company has established itself as a key contributor to the advancement of biotechnology, focusing on high-quality biosimilars and innovative drugs that address unmet medical needs. With a commitment to rigorous R&D and a collaborative approach to partnerships, including collaborations with internationally recognized institutions, Biokin is poised to enhance its product pipeline significantly. The company’s strong emphasis on biologic therapies positions it favorably within the industry, tapping into the growing global demand for effective, complex therapeutics that target various chronic and rare diseases. For investors, Sichuan Biokin represents a compelling opportunity due to its strategic positioning in a rapidly growing market segment that benefits from favorable governmental support for biotechnology innovation. As China's healthcare sector continues to expand, driven by an aging population and increasing investment in healthcare technology, Biokin’s strong foothold in biosimilars and the growing pipeline of innovative therapies suggest considerable future growth potential. Additionally, the company’s focus on adhering to international quality standards and gaining regulatory approvals could open doors to expand its market reach beyond China, enhancing long-term shareholder value. With a solid foundation in biotechnology and an ambitious vision for expansion, Sichuan Biokin is a company worth watching for investors looking to capitalize on the evolving pharmaceutical industry.

Intrinsic Value
47.96 CNY
Overvaluation 75%
Intrinsic Value
Price
S
What is Intrinsic Value?

See Also

What is Sichuan Biokin Pharmaceutical Co Ltd's Effect of Foreign Exchange Rates?
Effect of Foreign Exchange Rates
-2.6m CNY

Based on the financial report for Dec 31, 2023, Sichuan Biokin Pharmaceutical Co Ltd's Effect of Foreign Exchange Rates amounts to -2.6m CNY.

What is Sichuan Biokin Pharmaceutical Co Ltd's Effect of Foreign Exchange Rates growth rate?
Effect of Foreign Exchange Rates CAGR 3Y
-9%

The average annual Effect of Foreign Exchange Rates growth rates for Sichuan Biokin Pharmaceutical Co Ltd have been -9% over the past three years .

Back to Top
ALPHA SPREAD
Follow us
Join more than 201,300+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.